Skip to main content
. Author manuscript; available in PMC: 2017 Jul 14.
Published in final edited form as: J Med Chem. 2016 Jul 1;59(13):6531–6546. doi: 10.1021/acs.jmedchem.6b00760

Figure 1.

Figure 1

Inhibitor 1. (A) The chemical structure of compound 1. Pyrazolopyrimidine scaffold numbering and sites of inhibitor derivatization (R1 and R2) are shown. (B) Schematic of how 1 interacts with the ATP-binding site of TgCDPK1.